히알루론산 시장(2026-2030년)

The global hyaluronic acid market is forecasted to grow by USD 5576.9 mn during 2025-2030, accelerating at a CAGR of 8.6% during the forecast period. The report on the global hyaluronic acid market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for minimally invasive aesthetic procedures, growing geriatric demographic facing chronic conditions, expanding integration in advanced skincare formulations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global hyaluronic acid market is segmented as below:

By Application

• Dermal fillers
• Osteoarthritis
• Ophthalmic
• Vesicoureteral reflux

By End-User

• Pharmaceutical industry
• Cosmetic industry

By Product Type

• Liquid
• Gel
• Powder

Geography

• North America
  • US
  • Canada
  • Mexico
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• South America
  • Brazil
  • Argentina
  • Chile
• Rest of World (ROW)

This study identifies the expanding therapeutic applications in orthopedics as one of the prime reasons driving the global hyaluronic acid market growth during the next few years. Also, accelerating shift toward microbial fermentation production and proliferation of multifunctional hybrid filler formulations will lead to sizable demand in the market.

The report on the global hyaluronic acid market covers the following areas:

• Global hyaluronic acid market sizing
• Global hyaluronic acid market forecast
• Global hyaluronic acid market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global hyaluronic acid market vendors that include AbbVie Inc., Anika Therapeutics Inc., Bloomage Biotech Co. Ltd., Contipro AS, Croma Pharma GmbH, Fidia Farmaceutici S.p.A., FocusChem Biotech Co. Ltd., Galderma Group AG, Givaudan SA, Gnosis by Lesaffre, HTL Biotechnology SAS, Kewpie Corp., Kikkoman Biochemifa Co., LG Chem Ltd., Lifecore Biomedical Inc., Merz Pharma GmbH KGaA, Sanofi SA, Seikagaku Corp., Shiseido Co. Ltd., Titan Biotech Ltd., Zimmer Biomet Holdings Inc.. Also, the global hyaluronic acid market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Hyaluronic Acid Market 2020 - 2024
  • Historic Market Size - Data Table on Global Hyaluronic Acid Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Hyaluronic Acid Market
• 6.2 Impact of geopolitical conflicts on Global Hyaluronic Acid Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Dermal fillers - Market size and forecast 2025-2030
• 8.4 Osteoarthritis - Market size and forecast 2025-2030
• 8.5 Ophthalmic - Market size and forecast 2025-2030
• 8.6 Vesicoureteral reflux - Market size and forecast 2025-2030
• 8.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Pharmaceutical industry - Market size and forecast 2025-2030
• 9.4 Cosmetic industry - Market size and forecast 2025-2030
• 9.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Product Type

• 10.1 Market segments
• 10.2 Comparison by Product Type
• 10.3 Liquid - Market size and forecast 2025-2030
• 10.4 Gel - Market size and forecast 2025-2030
• 10.5 Powder - Market size and forecast 2025-2030
• 10.6 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 APAC - Market size and forecast 2025-2030
  • 12.4.1 China - Market size and forecast 2025-2030
  • 12.4.2 Japan - Market size and forecast 2025-2030
  • 12.4.3 India - Market size and forecast 2025-2030
  • 12.4.4 South Korea - Market size and forecast 2025-2030
  • 12.4.5 Australia - Market size and forecast 2025-2030
  • 12.4.6 Indonesia - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 UK - Market size and forecast 2025-2030
  • 12.5.3 France - Market size and forecast 2025-2030
  • 12.5.4 Italy - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 The Netherlands - Market size and forecast 2025-2030
• 12.6 Middle East and Africa - Market size and forecast 2025-2030
  • 12.6.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.2 UAE - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 Israel - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
• 12.7 South America - Market size and forecast 2025-2030
  • 12.7.1 Brazil - Market size and forecast 2025-2030
  • 12.7.2 Argentina - Market size and forecast 2025-2030
  • 12.7.3 Chile - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising demand for minimally invasive aesthetic procedures
  • Growing geriatric demographic facing chronic conditions
  • Expanding integration in advanced skincare formulations
• 13.2 Market challenges
  • Stringent and fluctuating global regulatory frameworks
  • Intense competitive rivalry and price erosion
  • High costs and limited reimbursement policies
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Expanding therapeutic applications in orthopedics
  • Accelerating shift toward microbial fermentation production
  • Proliferation of multifunctional hybrid filler formulations

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Segment focus
  • SWOT
• 15.5 Anika Therapeutics Inc.
  • Anika Therapeutics Inc. - Overview
  • Anika Therapeutics Inc. - Product / Service
  • Anika Therapeutics Inc. - Key offerings
  • SWOT
• 15.6 Bloomage Biotech Co. Ltd.
  • Bloomage Biotech Co. Ltd. - Overview
  • Bloomage Biotech Co. Ltd. - Product / Service
  • Bloomage Biotech Co. Ltd. - Key offerings
  • SWOT
• 15.7 Contipro AS
  • Contipro AS - Overview
  • Contipro AS - Product / Service
  • Contipro AS - Key offerings
  • SWOT
• 15.8 Croma Pharma GmbH
  • Croma Pharma GmbH - Overview
  • Croma Pharma GmbH - Product / Service
  • Croma Pharma GmbH - Key offerings
  • SWOT
• 15.9 Fidia Farmaceutici S.p.A.
  • Fidia Farmaceutici S.p.A. - Overview
  • Fidia Farmaceutici S.p.A. - Product / Service
  • Fidia Farmaceutici S.p.A. - Key offerings
  • SWOT
• 15.10 FocusChem Biotech Co. Ltd.
  • FocusChem Biotech Co. Ltd. - Overview
  • FocusChem Biotech Co. Ltd. - Product / Service
  • FocusChem Biotech Co. Ltd. - Key offerings
  • SWOT
• 15.11 Galderma Group AG
  • Galderma Group AG - Overview
  • Galderma Group AG - Business segments
  • Galderma Group AG - Key offerings
  • Galderma Group AG - Segment focus
  • SWOT
• 15.12 Givaudan SA
  • Givaudan SA - Overview
  • Givaudan SA - Business segments
  • Givaudan SA - Key news
  • Givaudan SA - Key offerings
  • Givaudan SA - Segment focus
  • SWOT
• 15.13 Gnosis by Lesaffre
  • Gnosis by Lesaffre - Overview
  • Gnosis by Lesaffre - Product / Service
  • Gnosis by Lesaffre - Key offerings
  • SWOT
• 15.14 HTL Biotechnology SAS
  • HTL Biotechnology SAS - Overview
  • HTL Biotechnology SAS - Product / Service
  • HTL Biotechnology SAS - Key offerings
  • SWOT
• 15.15 Kewpie Corp.
  • Kewpie Corp. - Overview
  • Kewpie Corp. - Business segments
  • Kewpie Corp. - Key offerings
  • Kewpie Corp. - Segment focus
  • SWOT
• 15.16 Kikkoman Biochemifa Co.
  • Kikkoman Biochemifa Co. - Overview
  • Kikkoman Biochemifa Co. - Product / Service
  • Kikkoman Biochemifa Co. - Key offerings
  • SWOT
• 15.17 LG Chem Ltd.
  • LG Chem Ltd. - Overview
  • LG Chem Ltd. - Business segments
  • LG Chem Ltd. - Key news
  • LG Chem Ltd. - Key offerings
  • LG Chem Ltd. - Segment focus
  • SWOT
• 15.18 Lifecore Biomedical Inc.
  • Lifecore Biomedical Inc. - Overview
  • Lifecore Biomedical Inc. - Product / Service
  • Lifecore Biomedical Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations